Digital Health Accelerators Digital Health Today Ambassadors Digital Health Today Podcast Digital Health Today-Resources Digital Health Today Ambassadors

Digital Health Today Podcasts

Accelerating innovation and implementation of health technology
Subscribe
Advertisement

Latest Episodes

Showing 1 - 8 of 119

Coffee Talk: How Corporations Adapt in the Face of New Challenges

Welcome back to Digital Health Today, the place to be to get the insights of leaders making the healthcare of tomorrow, available today. I’m your host, Dan Kendall and this is a Coffee Talk. Coffee Talks are opportunities to hear directly from the leaders of organizations that make our platform possible, and to keep up to date on the pivots and progress of the evolving digital health ecosystem. In this episode I welcome two executives from Bayer G4A. Bayer G4A has been a longtime sponsor of Digital Health Today. I caught up with Dominick Kennerson, Global Head G4A, Digital Health Partnerships at Bayer Pharmaceuticals. I also spoke with Sophie Park. Sophie is a veteran guest on the Digital Health Today program, and the Chief Strategist for Bayer G4A Partnerships. Dominick shared how a chance meeting at a Washington, D.C. bar began his path to a career in Europe. We also spoke about the impact of COVID-19 on the Bayer organization, and how it has changed the expectations and opportunities for companies of all sizes working to make a dent in healthcare. He also traces the early use of the term 'digital health' back to his time at Revolution Health. Agents of Change - A Virtual Digital Health Forum: Earlier this year, Bayer G4A had a call for applications. They are looking for innovative companies that are ready to make a difference in specific key challenge areas. After months of hard work and vetting all the applicants, they’re about to announce the finalists for this year’s Bayer G4A Program. While we don’t know the companies they’ve selected at the time of this recording, they will be announced very soon at a global virtual event taking place at 11am Eastern (5PM CET) on Wednesday, November 18, 2020. So, if you’re listening to this episode on or before Nov 18, click here to register to attend. If you’re tuning in on November 19 or later, scroll down to find names and links to the companies that have been accepted.  Now without further ado, let’s tune into the conversation with Dominick Kennerson and Sophie Park Welcome to the 2020 G4A Cohort! And the winners are.... going to be announced on November 18! Click here to register for the virtual event to be held at 11am Eastern, 5pm CET, on Wednesday November 18, 2020 Connect on Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Almirall Digital Garden Cedars-Sinai Accelerator University of Chicago - Master of Science in Biomedical Informatics Learn more about your ad choices. Visit megaphone.fm/adchoices
November 17, 2020 by Digital Health Today 360°

Trailer: Introducing Digital Therapeutics with Eugene Borukhovich

Join host Eugene Borukhovich as he explores how non-molecular therapies and interventions can prevent, manage or even cure diseases. In this limited series produced with Digital Health Today, learn about the rapidly evolving field of Digital Therapeutics, its history, the evolving regulatory and reimbursement frameworks, and the trailblazers creating and advancing this industry.
November 11, 2020 by Digital Therapeutics Edition

Introducing the Femtech Edition with Jen Lannon

Welcome to Digital Health Today with Jen Lannon. If you're interested in health innovation, you may have heard the word 'femtech' by now. It's projected to be a $50 billion market by 2025. In 2019, femtech companies received $800 million in venture investment. But what is 'femtech'? What should healthcare and technology professionals know about it? What are the hot new companies that are coming to market and who's paying for them? Women make up 56% of healthcare expenditures and 80% of healthcare purchasing decisions. It's critical for everyone in health and technology to have a basic understanding of women's health and femtech. That's why I'm interviewing world renowned experts who have taken their own personal and professional interest in this hot space. So tune in to Digital Health Today with me, Jen Lannon, to get the best insights into femtech, including what everyone in health innovation should know about it. Connect on Digital Health Today: Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable University of Chicago - Master of Science in Biomedical Informatics
October 25, 2020 by Femtech Edition

Introducing the Asia Pacific Edition, with Tony Estrella

In this extension to the long-running Digital Health Today series, Tony Estrella focuses in on the Asia Pacific region and dives into topics ranging from: how to segment this region of 40+ countries spanning over 4.6 billion people how are the traditional roles of patients, payers, and providers different in this region comparing and contrasting the challenges people face in healthcare across this region as compared to western countries what motivates some of the leading minds to push forward with disruptive solutions The Asia Pacific region is seeing exciting growth across all facets of digital health. Tony speaks with leaders and organizations in insurance, pharma, clinicians, medical devices, investors, entrepreneurs, and policy makers to provide you with insights to guide your interests in this region. Connect on Digital Health Today: Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable University of Chicago - Master of Science in Biomedical Informatics
October 20, 2020 by Asia Pacific Edition

Coffee Talk: How Digital Health Startups Respond and Thrive in a Global Pandemic

Imagine this: You’re the founder of a digital health startup. You’ve been carefully selected and invited to participate in a brand new accelerator in Barcelona. At the start of the year, you say goodbye to your friends and family, you find a place in Barcelona to call home, and you focus on growing your business with the mentorship and support of one of the world’s leading pharmaceutical companies.  And then, COVID-19 happens.  How does that impact your strategy? How will it affect your success? And will the fight you wage for survival have an impact the healthcare sector at large? In this Coffee Talk we speak with Carlos Gallardo, the CEO and Founder of CG Health Ventures and a board member at Almirall. He has invested personally in about a dozen companies - including Washington DC-based Babyscripts, whose co-founder Juan Pablo Segura was a guest on episode 67. Carlos is based in Barcelona, and he often takes an active role in helping his companies develop their product market fit.  Background: At the end of 2019, Almirall selected and invited 4 companies to participate in their first cohort - aka "First Harvest" - at the Digital Garden in beautiful Barcelona. Like all things in 2020, the plans had to change to adapt to our new reality. In the face of this global crisis, the startups have embraced and benefited from opportunities that no one predicted in January. And Almirall itself has benefited from the Digital Garden as well. In October 2020, Almirall launched their call for their second cohort - or, as they like to call it - their "Second Harvest."  Find out more by visiting the Almirall Digital Garden Website. Applications are open until October 31, 2020, so don’t delay. Links and Resources: Apply to Almirall Digital Garden - Deadline is Oct 31, 2020! Connect with Carlos Gallardo: LinkedIn | CG Health Ventures Digital Garden's First Harvest: Haut.ai Derma2Go Uvisio Intrepida Analytics Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable University of Chicago - Master of Science in Biomedical Informatics Learn more about your ad choices. Visit megaphone.fm/adchoices
October 12, 2020 by Digital Health Today 360°

S11: #108 – What the Clearance of Akili's EndeavorRX Means for the Company, Users and the Industry

If you’ve been tuned into nearly any news channel recently, you’ve probably seen the announcement by Akili about the clearance they announced on June 15 for their product EndeavorRX. It is the first prescription treatment delivered through a video game which is designed to treat Pediatric ADHD. This was quickly followed by an announcement on June 23, 2020 of their CE Mark certification. Like many of you I’ve been tracking the work and progress at Akili for a long time, and I was excited to hear about this important milestone, and when the Akili team contacted me to see if I wanted to have a closer look at and try Endeavor RX, I couldn’t resist. I’ve downloaded it to my iPad and gave it a try, and I’m impressed. I can’t speak to the clinical aspects of the product, but based on the standards and expectations that we have from consumer focused products, this was a great experience. It’s well-designed, was easy to get set up, and it uses a great combination of graphics and sounds to engage the player. I love the way they are positioning this with the simple and memorable tagline - “Play your medicine”. That sort of sums it up. To learn more about the importance of this milestone and go a little deeper behind the headlines, I grabbed a few minutes to connect with Eddie Martucci, the Co-Founder and CEO at Akili Interactive Labs. Eddie shares what the recent FDA clearance and CE Mark approval mean to the business. We also discuss the commercialization plans, the volume and value of data created by digital tools, and how Digital Medicine and Digital Therapeutics will continue to transform the relationship between companies and people. Links and Resources: Connect with Eddie Martucci, PhD: Twitter | LinkedIn Connect with Akili Interactive Labs: Website | Twitter | LinkedIn Read the Press Release for FDA Clearance Read the Press Release for CE Mark Certification Lancet Digital Health Journal summary for STARS-ADHD Download the App Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable University of Chicago - Master of Science in Biomedical Informatics Learn more about your ad choices. Visit megaphone.fm/adchoices
June 26, 2020 by Digital Health Today 360°

Coffee Talk: How Innovative Companies can Partner with a Global Pharma Brand

For this special Coffee Talk, I invited Sophie Park, Chief Strategist for Bayer G4A Partnerships to discuss the opportunities for innovative companies to grow and partner with a global pharma company. The Bayer G4A program has continued to grow and succeed since 2013, and it has evolved to adapt to changing market forces, new business priorities and the unprecedented acceleration of innovation that has taken place at the intersection of health and technology.  One of the challenges when an organization has a long history of success like that is that people begin to automatically associate what they knew about the program in previous years, and then overlay that to make presumptions about what the program is like this year.  For example - a lot of people think that G4A is simply an accelerator for early stage startups. In actual fact, they also have a very powerful partnership program which is designed to attract companies that can participate in joint ventures, commercial partnerships or even majority investments.   In this episode, we dispel some of these myths and give more insights on the progress and success of the G4A program and family. Learn more about Bayer G4A Partnership Links and Resources: Learn more about Bayer G4A: Web | Twitter Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram   Digital Health Today is made possible by the support of our sponsors. Thank you to University of Chicago - Master of Science in Biomedical Informatics Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable Learn more about your ad choices. Visit megaphone.fm/adchoices
June 11, 2020 by Digital Health Today 360°

S11: #107: To Bot or Not to Bot? The Rise of AI Chatbots in Healthcare in the Wake of COVID-19

When you visit a website, do you use the navigation menu? Or do you head to the lower right corner of your screen? T hat corner is where a little bit of internet magic happens and it’s becoming more prevalent, and having a great impact, in healthcare. It’s where you can get the answers and information you need just by typing in a few simple words or a question. That little chatbot can be repeated millions and billions of times and provide more natural human interactions and benefits to both the users and the organization that deployed it. To learn more about this technology and how it’s being applied in healthcare, I invited Dr. John Reeves to come share some insights.   Dr. Reeves is a global expert in the application of conversational AI to healthcare. He has over 25 years of experience as an engineer, primary care physician, and entrepreneur. He’s the CEO and founder of ConversationHealth, which is transforming how life sciences companies engage their patients and healthcare professionals through virtual conversations. Their company has developed a Pharma-specific SaaS platform that powers these human-like experiences across text, voice, and digital human channels, and he’s here to discuss some top tips about what companies should be thinking about when it comes to developing a chatbot solution of their own. John and his team put together a download we’re going to discuss - and I just want to remind you that the download and links to everything we discuss can be found in the show notes of your podcast player and at our website at digitalhealthtoday.com/podcasts. You can also find everything at our second home on Health Podcast Network on healthpodcastnetwork.com - along with hundreds of great episodes from outstanding podcasts across healthcare. Be sure to check that out. Episode Download: Download the Chatbot Canvas Links and Resources: Connect with Dr. John Reeves: LinkedIn Connect with Conversation Health: Website | Twitter | LinkedIn Connect on Digital Health Today: Browse Episodes | Twitter | Linkedin | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Almirall Digital Garden Bayer G4A Cedars-Sinai Accelerator Medable University of Chicago - Master of Science in Biomedical Informatics Learn more about your ad choices. Visit megaphone.fm/adchoices
May 26, 2020 by Digital Health Today 360°
Next Showing 1 - 8 of 119
cover
Coffee Talk: How Corporations Adapt in the Face of New Challenges Innovating at the speed of COVID-19. PLUS: Meet the new companies in the 2020 cohort of Bayer G4A
X
X